Watch PLRX. Know when insiders buy.
One email the day a filing lands. Free.
PLRX
PLIANT THERAPEUTICS, INC.
1.14
+0.01 +1.33%
USD · close Sep 24
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
11
FLAG · shorts 11
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $70.6MP/E —DIV YIELD —FCF YIELD -100.43%REV TTM —NET INCOME −$92.3MNET CASH $24.9M52W 1.03 – 1.87SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | — | — | — | −$23.9M | −$22.4M | — | -0.36 | −$12.8M | $0 | −$12.8M | Aug 11 |
| Q1 2026 · Mar 31 | — | — | — | −$21.8M | −$20M | — | -0.32 | −$19.2M | $0 | −$19.2M | Aug 11 |
| Q4 2025 · Dec 31derived | — | — | — | −$23.6M | −$23.6M | — | -0.38 | −$17.8M | $0 | −$17.8M | Mar 11 |
| Q3 2025 · Sep 30 | — | — | — | −$28.3M | −$26.3M | — | -0.43 | −$21.1M | $0 | −$21.1M | Nov 6 |
| Q2 2025 · Jun 30 | — | — | — | −$45.6M | −$43.3M | — | -0.71 | −$40.6M | $112K | −$40.7M | Aug 11 |
| Q1 2025 · Mar 31 | — | — | — | −$58.9M | −$56.2M | — | -0.92 | −$48.9M | $262K | −$49.1M | Aug 11 |
| Q4 2024 · Dec 31derived | $0 | — | — | −$53.3M | −$49.7M | — | -0.81 | −$47.7M | $209K | −$47.9M | Mar 11 |
| Q3 2024 · Sep 30 | $0 | — | — | −$62M | −$57.8M | — | -0.95 | −$32.3M | $896K | −$33.2M | Nov 6 |
| Q2 2024 · Jun 30 | $0 | — | — | −$60.6M | −$55.9M | — | -0.92 | −$45.3M | $1.3M | −$46.5M | Nov 6 |
| Q1 2024 · Mar 31 | $0 | — | — | −$52.4M | −$47M | — | -0.78 | −$30.3M | $1.5M | −$31.8M | Nov 6 |
| Q4 2023 · Dec 31derived | $0 | — | — | −$47M | −$41.1M | — | -0.69 | −$25.1M | $61K | −$25.2M | Mar 3 |
| Q3 2023 · Sep 30 | $0 | — | — | −$47.7M | −$41.5M | — | -0.70 | −$36.2M | $94K | −$36.3M | Nov 7 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $0 | — | −$156.4M | −$149.3M | — | -2.43 | −$128.3M | $374K | −$128.7M | — | — |
| FY2024 · to Dec 31 | $0 | — | −$228.4M | −$210.3M | — | -3.47 | −$155.5M | $3.8M | −$159.4M | — | — |
| FY2023 · to Dec 31 | $1.6M | — | −$184.1M | −$161.3M | -10211.1% | -2.75 | −$116.4M | $921K | −$117.3M | — | — |
| FY2022 · to Dec 31 | $9.7M | — | −$127.2M | −$123.3M | -1273.3% | -2.94 | −$94.6M | $1.8M | −$96.4M | — | — |
| FY2021 · to Dec 31 | $7.6M | — | −$97.5M | −$97.3M | -1284.5% | -2.71 | −$75.4M | $2M | −$77.4M | — | — |
| FY2020 · to Dec 31 | $41.8M | — | −$41.6M | −$41.5M | -99.3% | -1.95 | −$37.3M | $1.5M | −$38.8M | — | — |
Every number comes from PLIANT THERAPEUTICS, INC.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.